TYPE 2 DIABETES MELLITUS (T2DM)

This large, late-stage study is testing whether a new injectable drug called GZR18 works better and is as safe as existing diabetes medications. It involves 1100 Chinese adults whose type 2 diabetes is not well-controlled with their current metformin-based pills. The main goal is…

This study is testing a new digital platform called MPowerHub that helps adults with type 2 diabetes use information from wearable glucose and activity monitors to improve their daily self-care. Researchers will enroll 80 participants to see if the platform helps people stick to …

This study is testing a new surgical device that uses magnets to connect two parts of the small intestine. The goal is to see if this procedure is safe and can help adults with obesity, with or without type 2 diabetes, manage their weight and improve their blood sugar levels. The…

This study aimed to test if a single pill containing two common diabetes medications works better for blood sugar control than taking the medications separately. It was designed for adults with type 2 diabetes who were already taking metformin. The trial was withdrawn by the spon…

This study is testing two new injection medicines for adults with type 2 diabetes whose blood sugar is still too high despite taking a common class of injectable drugs (GLP-1RAs). Researchers want to see if a weekly shot (GZR102) works as well or better than a shot every two week…

This study looks at whether a common type of diabetes medication (SGLT2 inhibitors) helps prevent future heart problems in people who have both diabetes and a recent heart attack. Researchers will analyze health records from 200,000 patients in Korea to compare outcomes between t…

This study is testing a new injectable drug called maridebart cafraglutide for adults with type 2 diabetes. Over 400 participants will receive different doses or a placebo for 24 weeks to see how well it controls blood sugar and affects body weight. The main goal is to find the m…

This study is testing whether a new injectable medication called GZR18 can help control blood sugar and body weight in Chinese adults with type 2 diabetes. It compares the drug to a placebo (dummy injection) in people whose blood sugar is still too high despite diet and exercise.…

This study is testing a new weekly injection called MET097 to see if it helps adults with obesity or overweight and type 2 diabetes lose weight and better control their blood sugar. About 133 participants will receive either the real injection or a placebo (a dummy shot) for 28 w…

This study is testing a new injectable medication called UBT251 to see if it can help control blood sugar in people with type 2 diabetes. It will involve 211 adults and compare the new injection against a placebo and another standard diabetes drug over 24 weeks. The main goal is …

This study is testing whether exercise training, brain training, or a combination of both can help older adults who have had a stroke and also have high blood pressure or diabetes. Over 400 participants in several Chinese cities will be assigned to one of four groups for a year t…

This study is testing a digital tool called DIPAR to see if it helps adults with type 2 diabetes get their important health checks done on time. The tool sends reminders to patients' phones when their kidney and blood sugar tests are overdue. Researchers want to know if these rem…

This study is testing a new weekly injection called CT-388 to see if it can help people who are overweight or obese and have type 2 diabetes. About 360 participants will receive either the drug or a placebo (dummy shot) for 48 weeks. The main goals are to see how much weight peop…

This study aims to understand how weight-loss surgery helps improve type 2 diabetes in obese patients. Researchers will use MRI scans and blood tests to measure fat in the pancreas and insulin function before and after surgery. The goal is to see if reducing pancreatic fat leads …